Objectives: Little information is available concerning PCR-based direct detection of Trichomonas infections on archived Pap (Papanicolaou)-stained smears. This study investigates DNA extraction and amplification from archived Pap smears. Trichomonas vaginalis is a parasitic protozoan that infects the urogenital tract of women. Study Design: DNA from archived Pap-stained smears was successfully amplified using the nested PCR to investigate if it could be used for accurate detection and retrospective epidemiological investigations. Results: In our study, 98 (75.4%) out of 130 specimens of T. vaginalis Pap-stained smears were found to be positive by the nested PCR. Also, direct PCR on the archived Pap smears for identifying T. vaginalis gave a specificity of 100%. Conclusion: PCR-based Pap smears appear to offer an effective method to detect Trichomonas infection in archived samples, being rapid, highly specific and convenient for sampling, particularly in retrospective investigations.

Keywords:
Trichomonas vaginalis, Archived Pap smear, Nested PCR
1.
Sorvillo F, Smith L, Kerndt P, Ash L: Trichomonas vaginalis, HIV and African-Americans. Emerg Infect Dis 2001;7:927-932.
2.
Anorlu RI, Fagbenro-Beyioku AF, Fagorala T, Abudu OO, Galadanci HS: Prevalence of Trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria. Nigerian Postgrad Med J 2001;8:183-186.
3.
Krieger JN: Trichomoniasis in men: old issues and new data. Sex Transm Dis 1995;22:83-96.
4.
Burstein GR, Zenilman JM: Nongonococcal urethritis - a new paradigm. Clin Infect Dis 1999;28(suppl 1):66-73.
5.
Philipson EH, Super DM: Gestational diabetes mellitus: does it recur in subsequent pregnancy? Am J Obstet Gynecol 1989;160:1324-1331.
6.
Draper D, Parker R, Patterson E, et al: Detection of Trichomonas vaginalis in pregnant women with the InPouch TV culture system. J Clin Microbiol 1993;31:1016-1018.
7.
Krieger JN, Tam MR, Stevens CE, et al: Diagnosis of trichomoniasis: comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988;259:1223-1227.
8.
Riley DE, Roberts MC, Takayama T, Krieger JN: Development of a polymerase chain reaction-based diagnosis of Trichomonas vaginalis. J Clin Microbiol 1992;30:465-472.
9.
Lawing LF, Hedges SR, Schwebke JR: Detection of Trichomonas vaginalis in vaginal and urine specimens from women by culture and PCR. J Clin Microbiol 2000;38:3585-3588.
10.
Sturm PD, Connolly C, Khan N, Ebrahim S, Sturm AW: Vaginal tampons as specimen collection device for the molecular diagnosis of non-ulcerative sexually transmitted infections in antenatal clinic attendees. Int J STD AIDS 2004;15:94-98.
11.
Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM: Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis 2002;35:576-580.
12.
Espinosa N, Hernandez R, Lopez-Griego L, Arroyo R, Lopez-Villaseno RI: Differences between coding and noncoding regions in the Trichomonas vaginalis genome: an actin gene as a locus model. Acta Trop 2001;78:147-154.
13.
Schwebke JR, Burgess D: Trichomoniasis. Clin Microbiol Rev 2004;17:794-803.
14.
McGowin CL, Rohde RE, Redwine G: Trichomonas vaginalis: common, curable and in the diagnostic spotlight. Clin Lab Sci 2014;27:53-56.
15.
Kobayashi TK, Fujimoto T, Okamoto H, Yuasa M, Sawaragi I: Association of mast cells in vaginal trichomoniasis in endocervical smears. Acta Cytol 1983;27:133-137.
16.
Papanicolaou GN: A new procedure for staining vaginal smears. Science 1942;95:438-439.
17.
Avwioro OG: Histochemistry and Tissue Pathology, ed 2. Ibadan, Claverianum Press, 2010.
18.
Lobo TT, Feijo G, Carvalho SE, Costa PL, Chagas C, Xavier J, et al: A comparative evaluation of the Papanicolaou test for the diagnosis of trichomoniasis. Sex Transm Dis 2003;30:694-699.
19.
Okuyama T, Takahashi R, Mori M, Osaka M, Kobayashi TK, Maeda S: Polymerase chain reaction amplification of Trichomonas vaginalis DNA from Papanicolaou-stained smears. Diagn Cytopathol 1998;19:437-440.
20.
Gall K, Pavicic D, Pavelic J, Audy-Jukovic S, Pavelic K: PCR amplification of DNA from stained cytological smears. J Clin Pathol 1993;46:378-379.
21.
Nathan B, Appiah J, Saunders P, Heron D, Nichols T, Brum R, Alexander S, Baraitser P, Ison C: Microscopy outperformed in a comparison of five methods for detecting Trichomonas vaginalis in symptomatic women. Int J STD AIDS 2014, Epub ahead of print.
22.
Chen JT, Lane MA, Clark DP: Inhibitors of the polymerase chain reaction in Papanicolaou stain: removal with a simple destaining procedure. Acta Cytol 1996;40:873-877.
23.
Sciacchitano S, Paliotta DS, Nardi F, Sacchi A, Andreoli M, Pontecorvi A: PCR amplification and analysis of RAS oncogenes from thyroid cytologic smears. Diagn Mol Pathol 1994;3:114-121.
24.
Boulet GA, Horvath CA, Berghmans S, Moeneclaey LM, Duys IS, Arbyn M, Depuydt CE, Vereecken AJ, Sahebali S, Bogers JJ: Cervical cytology biobanking: quality of DNA from archival cervical Pap-stained smears. J Clin Pathol 2008;61:637-641.
25.
Patel SR, Wiese W, Patel SC, Ohl C, Byrd JC, Estrada CA: Systematic review of diagnostic tests for vaginal trichomoniasis. Infect Dis Obstet Gynecol 2000;8:248-257.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.